Pune, Maharashtra -- (SBWIRE) -- 03/15/2019 -- According to a recent study by Fact.MR, the global breast cancer diagnostics market is projected to register a moderate CAGR of 4.7% during the forecast period 2017 to 2022. The report estimates the market to surpass US$ 2,000 Mn in revenues by 2022-end.

In diagnostic platforms of breast cancer, a number of technological advancements have led towards a robust transformation of the global market for breast cancer diagnostics. The emergence of hybrid diagnostics instruments with the provision of an enhanced accuracy have been witnessed in the market. Advancements such as these have been fuelling growth of the global market for breast cancer diagnostics. Surging cases of breast cancer, coupled with growing older women population are anticipated to create potential growth opportunities for breast cancer diagnostics market across the globe. However, lack of skilled as well as trained personnel is expected to inhibit the demand for breast cancer diagnostics during the forecast period.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=55

The most common type of cancer for women across the globe currently is breast cancer. The number of breast cancer cases is expected to witness a rise, leading towards the requirement for efficient and early breast cancer detection. An established method, mammography, adopted in many countries, has recently been observed to provide inconclusive test results. Personalized and risk-adapted therapy are expected to resolve these difficulties. Tomosythesis, which has emerged as a new imaging technology, promises to overcome the challenges incurred in mammography.

8 Estimations for the Global Breast Cancer Diagnostics Market

By test type, BRCA will remain dominant in the global breast cancer diagnostics market.
CA test for diagnostics of breast cancer is expected to register the highest CAGR through 2022 in the market, followed by ER & PR. Revenue from ER & PR, and CA tests will continue to be low throughout the forecast period.
HER 2 test is expected to remain the second largest segment among test type, in the market. However, EGFR mutation test is estimated to account for low revenues in the global market for breast cancer diagnostics.
North America will continue to be the largest market for breast cancer diagnostics. Revenues from breast cancer diagnostics market in North America is estimated to surpass US$ 800 Mn by 2022-end.
Europe will remain the second most lucrative region for the breast cancer diagnostics market. However, markets in Japan, and Middle East & Africa (MEA) are anticipated to witness a sluggish expansion throughout the forecast period.
Hospital-associated labs will remain sought-after among end-users for breast cancer diagnostics around the world. Revenues from breast cancer diagnostics will remain largest in hospital-associated labs, followed by the independent diagnostic laboratories.
Cancer research institutes are anticipated to exhibit the highest CAGR during the forecast period. Between 2017 and 2022, cancer research institutes are estimated to create absolute $ opportunity of US$ 107.3 Mn.
Key market players mentioned in Fact.MR's report include Siemens AG, Myriad Genetics, Inc., Roche Holding AG, Illumina, Inc., Epigenomics AG, Abbott Laboratories, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., Biocept, Inc., AstraZeneca plc, and Quest Diagnostics Incorporated.
Browse Full Report @ https://www.factmr.com/report/55/breast-cancer-diagnostics-market

Table of Contents Covered in the report are:

Chapter 1 Global Breast Cancer Diagnostics Market - Executive Summary 19

Chapter 2 Global Breast Cancer Diagnostics Market Overview 21
2.1 Introduction 21
2.1.1 Global Breast Cancer Diagnostics Market Taxonomy 21
2.1.2 Global Breast Cancer Diagnostics Market Definition 21
2.2 Global Breast Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 22
2.2.1 Global Breast Cancer Diagnostics Market Y-o-Y Growth 22
2.3 Global Breast Cancer Diagnostics Market Dynamics 22
2.3.1 Drivers 22
2.3.2 Restraints 22
2.3.3 Trends 23
2.4 Supply Chain 23
2.5 Epidemiology 23
2.6 List of Distributors 23
2.7 Average Pricing Analysis 23
2.8 Regulations 24
2.9 Key Participants Market Presence (Intensity Map) By Region 24

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=55

Chapter 3 Global Breast Cancer Diagnostics Market Analysis and Forecast By Test Type 25
3.1 Global Breast Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 25
3.1.1 BRCA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 25
3.1.1.1 Revenue (US$ Mn) Comparison, By Region 25
3.1.1.2 Market Share Comparison, By Region 26
3.1.1.3 Y-o-Y growth Comparison, By Region 27
3.1.2 ER & PR Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 28
3.1.2.1 Revenue (US$ Mn) Comparison, By Region 28
3.1.2.2 Market Share Comparison, By Region 29
3.1.2.3 Y-o-Y growth Comparison, By Region 30
3.1.3 CEA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 31
3.1.3.1 Revenue (US$ Mn) Comparison, By Region 31
3.1.3.2 Market Share Comparison, By Region 32
3.1.3.3 Y-o-Y growth Comparison, By Region 33
3.1.4 KRAS Mutation Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 34
3.1.4.1 Revenue (US$ Mn) Comparison, By Region 34
3.1.4.2 Market Share Comparison, By Region 35
3.1.4.3 Y-o-Y growth Comparison, By Region 36
3.1.5 HER 2 Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 37
3.1.5.1 Revenue (US$ Mn) Comparison, By Region 37
3.1.5.2 Market Share Comparison, By Region 38
3.1.5.3 Y-o-Y growth Comparison, By Region 39
3.1.6 PSA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 40
3.1.6.1 Revenue (US$ Mn) Comparison, By Region 40
3.1.6.2 Market Share Comparison, By Region 41
3.1.6.3 Y-o-Y growth Comparison, By Region 42
3.1.7 CA Test Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 43
3.1.7.1 Revenue (US$ Mn) Comparison, By Region 43
3.1.7.2 Market Share Comparison, By Region 44
3.1.7.3 Y-o-Y growth Comparison, By Region 45
3.1.8 EGFR Mutation Test Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 46
3.1.8.1 Revenue (US$ Mn) Comparison, By Region 46
3.1.8.2 Market Share Comparison, By Region 47
3.1.8.3 Y-o-Y growth Comparison, By Region 48
3.1.9 Immunohistochemistry Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 49
3.1.9.1 Revenue (US$ Mn) Comparison, By Region 49
3.1.9.2 Market Share Comparison, By Region 50
3.1.9.3 Y-o-Y growth Comparison, By Region 51
3.1.10 Others Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 52
3.1.10.1 Revenue (US$ Mn) Comparison, By Region 52
3.1.10.2 Market Share Comparison, By Region 53
3.1.10.3 Y-o-Y growth Comparison, By Region 54

Chapter 4 Global Breast Cancer Diagnostics Market Analysis and Forecast By End User 55
4.1 Global Breast Cancer Diagnostics Market Size and Forecast By End User, 2012-2022 55
4.1.1 Hospital Associated Labs Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 55
4.1.1.1 Revenue (US$ Mn) Comparison, By Region 55
4.1.1.2 Market Share Comparison, By Region 57
4.1.1.3 Y-o-Y growth Comparison, By Region 57
4.1.2 Independent Diagnostic Laboratories Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 58
4.1.2.1 Revenue (US$ Mn) Comparison, By Region 58
4.1.2.2 Market Share Comparison, By Region 60
4.1.2.3 Y-o-Y growth Comparison, By Region 60
4.1.3 Cancer Research Institutes Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 61
4.1.3.1 Revenue (US$ Mn) Comparison, By Region 61
4.1.3.2 Market Share Comparison, By Region 63
4.1.3.3 Y-o-Y growth Comparison, By Region 63
4.1.4 Others Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 64
4.1.4.1 Revenue (US$ Mn) Comparison, By Region 64
4.1.4.2 Market Share Comparison, By Region 66
4.1.4.3 Y-o-Y growth Comparison, By Region 66

And Continue...

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Web: https://www.factmr.com/ 
Read Industry News at - https://theswisstimes.com